Ownership

Who owns LIFECORE BIOMEDICAL, INC. \DE\, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

BlackRock, Inc. July 29, 2026

BlackRock, Inc.: 5.4% · 2,010,546 shares

View filing (SCHEDULE 13G)

22NW Fund, LP, 22NW, LP, 22NW Fund GP, LLC July 02, 2026

22NW Fund, LP: 6.7% · 2,712,472 shares — 22NW, LP: 6.7% · 2,712,472 shares — 22NW Fund GP, LLC: 6.7% · 2,712,472 shares

View filing (SCHEDULE 13D/A) Amendment #8

4 more 5% stakes behind a free account

See every investor who has disclosed crossing 5% of LIFECORE BIOMEDICAL, INC. \DE\.

Super investors holding LFCR

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of LIFECORE BIOMEDICAL, INC. \DE\ they hold. Together these 135 managers report 73.19% of shares outstanding.

Investor	Position value	Shares	% of their portfolio	% of company	As of
WYNNEFIELD CAPITAL INC	$24.7M	4,703,216	16.98%	12.42%	June 30, 2026
Legion Partners Asset Management, LLC	$23.4M	4,461,823	57.75%	11.79%	June 30, 2026

133 more institutional holders behind a free account

See every manager reporting LIFECORE BIOMEDICAL, INC. \DE\, how much of the company they hold, and how big the position is inside their own portfolio.

Funds holding LFCR

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 100 funds hold 9.68% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.

Fund	Position value	% of net assets	% of company	As of
VANGUARD TOTAL STOCK MARKET INDEX FUND	$4.32M	0.00%	2.17%	June 30, 2026
iShares Russell 2000 ETF	$2.47M	0.00%	1.76%	March 31, 2026

98 more funds behind a free account

See every fund holding LIFECORE BIOMEDICAL, INC. \DE\ and what share of its net assets the position represents.